KATIE LAHUSEN: Open Payments
NPI 1336601483 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 25 payments from 13 companies in 2025. Trend: 2023 $1,107 · 2024 $887 · 2025 $655
Food & beverage: $655
| Company | Payments | Amount |
|---|---|---|
| Impulse Dynamics (USA) Inc. | 1 | $152 |
| Tandem Diabetes Care, Inc. | 3 | $87 |
| Novo Nordisk Inc | 4 | $79 |
| Ascendis Pharma Endocrinology Inc | 4 | $67 |
| Dexcom, Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Lilly USA, LLC | 2 | $34 |
| Corcept Therapeutics | 1 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
Products named: Optimizer, t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter, Yorvipath, LEQVIO, MOUNJARO, Korlym, TZIELD.
Industry payments across OR — which companies pay providers there.
